Table 3.
Spearman's Rank Correlation Coefficient (r s) | P Value | |
---|---|---|
Age, y | −0.07 | 0.57 |
Sex | −0.11 (χ²=2.26) | 0.33 |
BMI, kg/m² | 0.07 | 0.56 |
NYHA class | 0.38 (χ²=12.97) | 0.001 |
NT‐proBNP*, mg/dL | 0.55 | <0.001 |
eGFR, mL/min | −0.51 | <0.001 |
Creatinine, mg/dL | 0.36 | 0.001 |
LE‐positive myocardial volume, % | 0.82 | <0.001 |
MRI‐LVMI, g/m² | 0.55 | <0.001 |
Echo‐LVMI, g/m² | 0.09 | 0.31 |
IVSd, mm | 0.74 | <0.001 |
LVPWd, mm | 0.70 | <0.001 |
LV end‐diastolic dimension, mm | −0.05 | 0.77 |
EF, % | 0.17 | 0.15 |
Left atrial diameter, mm | 0.44 | <0.001 |
E/e′ | 0.69 | <0.001 |
DT | 0.19 | 0.10 |
SPAP | 0.20 | 0.10 |
BMI indicates body mass index; DT, deceleration time of early filling; E/E′, mitral inflow velocity (E) to tissue Doppler E′ ratio; EF, ejection fraction; eGFR, estimated glomerular filtration rate; hs‐TNT, high‐sensitivity cardiac troponin T; IVSd, end‐diastolic interventricular septal wall thickness; LE, late enhancement; LV, left ventricle; LVMI, LV mass indexed to body surface area; LVPWd, end‐diastolic posterior wall thickness; NT‐proBNP, N‐terminal of the prohormone brain natriuretic peptide; NYHA, New York Heart Association; SPAP, systolic pulmonary artery pressure.
*Ln‐transformed.